HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Enzo Medico Selected Research

Aneurysm (Aneurysms)

12/2021MEK Inhibition in a Newborn with RAF1-Associated Noonan Syndrome Ameliorates Hypertrophic Cardiomyopathy but Is Insufficient to Revert Pulmonary Vascular Disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Enzo Medico Research Topics

Disease

48Neoplasms (Cancer)
01/2024 - 12/2004
22Colorectal Neoplasms (Colorectal Cancer)
04/2024 - 05/2011
7Neoplasm Metastasis (Metastasis)
01/2018 - 03/2008
5Breast Neoplasms (Breast Cancer)
03/2024 - 01/2018
4Carcinoma (Carcinomatosis)
01/2018 - 08/2010
3Disease Progression
01/2020 - 06/2012
3Stomach Neoplasms (Stomach Cancer)
11/2019 - 01/2015
3Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
01/2018 - 03/2010
3Lymphoma (Lymphomas)
01/2018 - 11/2012
2Melanoma (Melanoma, Malignant)
01/2024 - 01/2023
2Mucinous Adenocarcinoma (Mucinous Carcinoma)
01/2023 - 01/2017
2Carcinogenesis
01/2022 - 08/2010
2Glioblastoma (Glioblastoma Multiforme)
10/2020 - 09/2012
2Rectal Neoplasms (Rectal Cancer)
01/2018 - 04/2015
2Hypertrophy
01/2016 - 01/2016
2Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
05/2012 - 03/2012
1Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer)
01/2023
1Hypophosphatemic Rickets
12/2022
1Lymphangioma (Cavernous Lymphangioma)
12/2022
1Hamartoma
12/2022
1Nevus (Nevi)
12/2022
1Chylothorax
12/2022
1Choristoma (Ectopic Tissue)
12/2022
1Hypophosphatemia
12/2022
1Rickets (Rachitis)
12/2022
1Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
09/2022
1Adenoma (Adenomas)
01/2022
1Intestinal Neoplasms (Intestinal Cancer)
01/2022
1Pulmonary Hypertension
12/2021
1Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy)
12/2021
1Vascular Diseases (Vascular Disease)
12/2021
1Aneurysm (Aneurysms)
12/2021
1Hydrocephalus (Hydrocephaly)
12/2021
1Noonan Syndrome (Female Pseudo-Turner Syndrome)
12/2021
1Sarcoma (Soft Tissue Sarcoma)
12/2020
1Pseudomyxoma Peritonei
06/2020
1Appendiceal Neoplasms (Appendix Cancer)
06/2020
1Residual Neoplasm
01/2020

Drug/Important Bio-Agent (IBA)

10Proteins (Proteins, Gene)FDA Link
09/2022 - 03/2008
7Biomarkers (Surrogate Marker)IBA
01/2024 - 11/2011
6Cetuximab (Erbitux)FDA Link
04/2024 - 11/2011
6ErbB Receptors (EGF Receptor)IBA
10/2020 - 11/2011
5Phosphotransferases (Kinase)IBA
12/2018 - 01/2009
5Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
01/2016 - 09/2009
4RNA (Ribonucleic Acid)IBA
10/2020 - 04/2011
4tyrosine receptor (receptor, tyrosine)IBA
12/2018 - 01/2009
4Messenger RNA (mRNA)IBA
01/2016 - 04/2011
3pevonedistatIBA
01/2023 - 01/2017
3Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
12/2022 - 06/2012
3AntibodiesIBA
01/2020 - 11/2011
3LigandsIBA
01/2020 - 05/2011
3Anaplastic Lymphoma KinaseIBA
01/2018 - 03/2010
3MicroRNAs (MicroRNA)IBA
01/2016 - 01/2014
2Aurora Kinase AIBA
04/2024 - 03/2024
2Immune Checkpoint InhibitorsIBA
01/2024 - 01/2023
2Calcibiotic Root Canal SealerIBA
01/2023 - 07/2015
2Proteasome Endopeptidase Complex (Proteasome)IBA
01/2023 - 12/2013
2Proteasome InhibitorsIBA
01/2023 - 12/2013
2DNA (Deoxyribonucleic Acid)IBA
12/2022 - 01/2017
2AgarIBA
08/2021 - 11/2013
2RNA-Binding Proteins (RNA-Binding Protein)IBA
08/2021 - 02/2017
2Phenobarbital (Luminal)FDA Link
10/2020 - 01/2018
2Semaphorins (Semaphorin)IBA
01/2019 - 05/2008
2PLX 4720IBA
01/2017 - 12/2013
2Panitumumab (Vectibix)FDA Link
07/2015 - 06/2012
2Proto-Oncogene Proteins c-metIBA
06/2013 - 04/2011
2Oncogene Proteins (Oncogene Protein)IBA
11/2012 - 11/2011
2OligonucleotidesIBA
06/2012 - 03/2008
1Bortezomib (Velcade)FDA Link
01/2023
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
01/2023
1Cadherins (E-Cadherin)IBA
01/2023
1Differentiation AntigensIBA
01/2023
1Phosphates (Orthophosphate)IBA
12/2022
1neuroligin 1IBA
09/2022
1CateninsIBA
09/2022
1Histone Deacetylases (Histone Deacetylase)IBA
01/2022
1Glucose (Dextrose)FDA LinkGeneric
01/2022
1Pyruvate Dehydrogenase Acetyl-Transferring KinaseIBA
01/2022
1trametinibIBA
12/2021
1regorafenibIBA
11/2021
1Enzyme Inhibitors (Inhibitors, Enzyme)IBA
07/2021
1Heme (Haem)IBA
01/2021
1chondroitin sulfate proteoglycan 4IBA
12/2020
1Chimeric Antigen ReceptorsIBA
12/2020
1CytokinesIBA
12/2020
1Dexfenfluramine (Redux)IBA
10/2020
1olaparibIBA
01/2020
1Fluorouracil (Carac)FDA LinkGeneric
01/2020
1Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2020
1human ERBB2 proteinIBA
01/2020
1Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2020
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
01/2020

Therapy/Procedure

26Therapeutics
03/2024 - 05/2008
3Precision Medicine
11/2019 - 11/2011
2Drug Therapy (Chemotherapy)
01/2018 - 12/2014
1Immunotherapy
01/2023
1Ventriculoperitoneal Shunt
12/2021
1Hyperthermic Intraperitoneal Chemotherapy
06/2020
1Cytoreduction Surgical Procedures
06/2020
1Aftercare (After-Treatment)
01/2020